image
Syros Pharmaceuticals, Inc. SYRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.2593
-5.74 %
$ 6.96 M
Market Cap
-0.08
P/E
BALANCE SHEET
168 M ASSETS
-31.21%
Growth Rates
1Year -31.21%
3Years -7.61%
5Years 9.51%
7Years 9.11%
10Years 42.35%
152 M LIABILITIES
29.77%
Growth Rates
1Year 29.77%
3Years 7.28%
5Years 39.99%
7Years 45.99%
10Years 66.78%
16.7 M EQUITY
-86.96%
Growth Rates
1Year -86.96%
3Years -43.12%
5Years -26.67%
7Years -20.16%
10Years 15.41%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Syros Pharmaceuticals, Inc.
image
Current Assets 145 M
Cash & Short-Term Investments 140 M
Receivables 0
Other Current Assets 5.45 M
Non-Current Assets 23.2 M
Long-Term Investments 0
PP&E 19.5 M
Other Non-Current Assets 3.71 M
Current Liabilities 36.7 M
Accounts Payable 11.5 M
Short-Term Debt 11.3 M
Other Current Liabilities 13.8 M
Non-Current Liabilities 115 M
Long-Term Debt 53.1 M
Other Non-Current Liabilities 61.7 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 139.5 167.5 92.3 174.0 41.4 49.9 32.2 58.6 35.9 60.4 3.8
Short Term Investments 0 34.8 38.1 0 50.0 49.8 39.8 25.0 0 0 0
Receivables 0 1.7 3.0 2.3 20.2 0 0 0.9 0 0 0
Inventory 0 1 0 1 0.3 0 0 1 0 0 0
Other Current Assets 5.5 7.4 3.2 2.2 2.9 2.1 1.1 2.1 0.5 0.1 0.1
Total Current Assets 145.0 211.4 136.6 178.6 114.5 101.7 73.2 85.5 36.4 60.5 3.9
PP&E 19.5 24.7 27.3 29.6 31.9 3.9 3.9 4.8 4.8 0.9 0.9
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 3.1 13.0 3.1 3.1 0.3 0.3 0.5 0.5 0 0
Other Long Term Assets 3.7 5.3 6.0 2.0 0.5 0.9 1.1 0.5 1.9 70 K 70 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 168.2 244.5 182.9 213.2 150.0 106.8 78.5 91.3 43.6 61.5 4.9
LIABILITIES
Accounts Payable 11.5 6.4 3.7 3.6 5.9 3.3 2.3 2.4 5.0 0.9 0.6
Short Term Debt 11.3 4.1 4.0 3.5 2.6 18 K 94 K 0.3 0.1 0 0
Other Current Liabilities 13.8 15.9 13.6 9.4 9.4 14.3 10.0 6.3 2.8 0.3 0.3
Total Current Liabilities 36.7 30.8 31.5 28.6 23.5 19.5 12.4 9.6 8.0 1.3 0.9
Long Term Debt 53.1 61.5 63.2 64.5 24.6 22 K 6 K 53 K 0.2 0 0
Deferred Tax Income 0 0 0 0 (22.6) 22 K 0 0 0 0 0
Other Liabilities 61.7 24.5 3.0 19.7 0 0.4 0.7 1.1 1.4 1 K 0
Total Liabilities 151.5 116.8 97.7 122.7 70.8 28.2 13.2 10.7 9.6 1.3 0.9
EQUITY
Common Stock 26 K 20 K 61 K 56 K 43 K 34 K 26 K 23 K 2 K 1 K 5 K
Retained Earnings (722.8) (558.2) (463.6) (377.0) (293.0) (217.5) (155.3) (101.3) (53.5) (23.7) (10.3)
Other Accumulative Comprehensive Income/Loss 0 0.1 79 K 0 24 K 3 K 42 K 9 K (0.9) (0.4) 0
Total Equity 16.7 127.7 85.2 90.6 79.2 78.6 65.3 80.6 34.0 60.2 4.0
Total Liabilities and Equity 168.2 244.5 182.9 213.2 150.0 106.8 78.5 91.3 43.6 61.5 4.9
SHARES OUTSTANDING
Common Shares Outstanding 28.3 12.6 6.3 4.6 4.0 3.3 2.5 1.3 0.2 0.2 0.1